烧伤患者消化道选择性去污染:系统综述与Meta分析
该系统综述与Meta分析纳入4项随机对照试验共457例烧伤患者,评估消化道选择性去污染(SDD)对比安慰剂或无SDD的效果。所有结局证据确定性均为极低,30天死亡率RR 0.62(95%CI 0.22-1.78,I²=75%,随机效应模型),肺炎RR 0.75(95%CI 0.48-1.19,I²=0%,固定效应模型),血流感染RR 1.10(95%CI 0.71-1.69,I²=0%,随机效应模型),住院时间平均差-2.03天(95%CI -9.64-5.59,I²=51%,随机效应模型)。结论认为证据确定性极低,在更多烧伤患者RCT数据出现前,从机械通气成人ICU患者证据外推可能是合理的。
要点
- 4项RCT共457例烧伤患者,所有试验偏倚风险为「有些担忧」或「高风险」。
- 30天死亡率RR 0.62(95%CI 0.22-1.78,I²=75%,极低确定性证据)。
- 肺炎RR 0.75(95%CI 0.48-1.19,I²=0%,极低确定性证据)。
核心结论
- 烧伤患者中SDD对患者重要结局的证据确定性极低。
- 在更多烧伤患者RCT数据出现前,从机械通气成人ICU患者证据外推可能是合理的。
研究设计与样本
- 系统综述与Meta分析,纳入评估SDD对比安慰剂或无SDD的随机对照试验(RCT)。
- 共纳入4项RCT,总计457例烧伤患者。
- 检索所有主要数据库,遵循Cochrane协作网和PRISMA指南,采用GRADE方法评估证据确定性。
主要发现
- 所有试验偏倚风险评为「有些担忧」或「高风险」。
- 30天死亡率RR 0.62(95%CI 0.22-1.78,I²=75%,随机效应模型,极低确定性证据)。
- 肺炎RR 0.75(95%CI 0.48-1.19,I²=0%,固定效应模型,极低确定性证据)。
- 血流感染RR 1.10(95%CI 0.71-1.69,I²=0%,随机效应模型,极低确定性证据)。
- 住院时间平均差-2.03天(95%CI -9.64-5.59,I²=51%,随机效应模型,极低确定性证据)。
关键数值与推荐
- 主要结局为30天死亡率;次要结局包括严重不良事件、抗菌药物耐药、肺炎、血流感染、ICU-free days和hospital-free days及90天死亡率。
- 所有结局证据确定性均为极低。
- 30天死亡率RR 0.62(95%CI 0.22-1.78,I²=75%,随机效应模型)。
- 肺炎RR 0.75(95%CI 0.48-1.19,I²=0%,固定效应模型)。
- 血流感染RR 1.10(95%CI 0.71-1.69,I²=0%,随机效应模型)。
临床怎么用
- 作者认为,在更多烧伤患者RCT数据出现前,从机械通气成人ICU患者证据外推可能是合理的。
局限性
- 所有纳入试验偏倚风险评为「有些担忧」或「高风险」。
- 所有结局证据确定性均为极低。
- 因数据有限或无数据,未对其余次要结局进行Meta分析。
- 因纳入试验总参与者数和事件数不足,无法进行试验序贯分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In mechanically ventilated adult patients in the intensive care unit (ICU), selective decontamination of the digestive tract (SDD) has been shown to reduce the risk of infections and improve survival. While the benefits of SDD have been documented in this population, it remains unclear whether burn patients, who are at increased risk of infection and have distinct clinical characteristics, may experience similar benefits. In this systematic review we aimed to assess the desirable and undesirable patient-important effects of administering SDD to burn patients. METHODS/DESIGN: We conducted a systematic review with meta-analysis of randomized clinical trials (RCTs) assessing the effects of SDD versus placebo or no SDD in burn patients. The primary outcome was 30-day mortality. Secondary outcomes included serious adverse events, antimicrobial resistance, pneumonia, blood stream infections, ICU- and hospital-free days, and 90-day mortality. We searched all major databases and followed the recommendations provided by the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The certainty of evidence was assessed according to the Grading of Recommendations Assessment, Development, and Evaluation approach. RESULTS: We identified four RCTs with a total of 457 burn patients. All trials were assessed as having either 'some concerns' or 'high risk' of bias. The evidence was found to be very uncertain across all outcomes assessed. For mortality, the relative risk (RR) was 0.62 (95 % confidence interval (CI) 0.22-1.78, I2 = 75 %, random-effects model (REM), very low certainty evidence). For pneumonia, the RR was 0.75 (95 % CI 0.48-1.19, I2 = 0 %, fixed-effect model, very low certainty evidence). For bloodstream infections, the RR was 1.10 (95 % CI 0.71-1.69, I2 = 0 %, REM, very low certainty evidence). For hospital length of stay, the mean difference was -2.03 days (95 % CI -9.64-5.59, I2 = 51 %, REM, very low certainty evidence). We did not perform meta-analyses for the remaining secondary outcomes due to limited or no data. Trial sequential analysis could not be performed due to insufficient number of total participants and events in the included trials. CONCLUSION: We found that the certainty of evidence is very low about the effects of SDD on patient-important outcomes in burn patients. Extrapolating from the evidence on mechanically ventilated adult ICU patients may be reasonable until more data from RCTs in burn patients emerge.
引用
- Tsuchiya EA, Jensen-Abbew J, Krag M, et al. Selective decontamination of the digestive tract in burn patients: A systematic review with meta-analysis. Burns. 2025. PMID: 40250196. doi:10.1016/j.burns.2025.107501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。